Skip to main content

Table 3 Summary of the quality of evidence (GRADE) for comparing systemic lidocaine to a control group for the primary and secondary outcomes of the included studies

From: The effect of systemic lidocaine on post-operative opioid consumption in ambulatory surgical patients: a meta-analysis of randomized controlled trials

# Studies in design (n)

Risk of bias

Inconsistency

Indirectness

Imprecision

Publication bias

Overall quality of evidenced

Postoperative opioid consumption at 24 h

5 (297)

Not seriousa

Not serious

Not serious

Seriousb

Undetected

Moderate

Postoperative opioid consumption at PACU

3 (169)

Not seriousa

Not serious

Not serious

Seriousb

Detectedc

Low

Postoperative pain at rest at 24 h

4 (218)

Not seriousa

Not serious

Not serious

Seriousb

Undetected

Moderate

Postoperative pain at rest at PACU

4 (218)

Not seriousa

Not serious

Not serious

Seriousb

Undetected

Moderate

Postoperative nausea and vomiting

4 (254)

Not seriousa

Not serious

Not serious

Seriousb

Undetected

Moderate

  1. aMajority of studies had allocation concealment and used blinded outcome assessments; lost to follow-up was very low; the overall risk of bias was felt to be not serious
  2. bImprecise due to wide confidence interval; few numbers of events
  3. cEgger’s regression test revealed a one-sided P = 0.03
  4. dGrade Workshop Group grades of evidence: high quality, further research very unlikely to change confidence in estimate of effect; moderate quality, further research likely to have important impact on confidence in estimate of effect and may change estimate; low quality, further research very likely to have important impact on confidence in estimate of effect and likely to change estimate; very low quality, very uncertain about estimate